BioLife Sciences Inc. (BLFE)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2022 | - USD | 0.0% |
| 2021 | - USD | 100.0% |
| 2020 | -1.26 Million USD | -111693.47% |
| 2019 | -1134.00 USD | 97.85% |
| 2018 | -52.71 Thousand USD | 84.51% |
| 2017 | -340.38 Thousand USD | -1675.16% |
| 2016 | -19.17 Thousand USD | 33.6% |
| 2015 | -28.88 Thousand USD | 0.0% |
| 2007 | -2.04 Million USD | -602.64% |
| 2006 | -291.19 Thousand USD | 39.27% |
| 2005 | -479.47 Thousand USD | -2584.64% |
| 2004 | -17.86 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q2 | - USD | 0.0% |
| 2023 Q1 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2022 Q1 | -132.05 USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2021 FY | - USD | 100.0% |
| 2021 Q2 | -137.75 Thousand USD | -104.51% |
| 2021 Q1 | -67.35 Thousand USD | 0.0% |
| 2021 Q3 | -143.16 Thousand USD | -3.93% |
| 2020 FY | -1.26 Million USD | -111693.47% |
| 2019 FY | -1134.00 USD | 97.85% |
| 2018 FY | -52.71 Thousand USD | 84.51% |
| 2017 FY | -340.38 Thousand USD | -1675.16% |
| 2016 FY | -19.17 Thousand USD | 33.6% |
| 2015 FY | -28.88 Thousand USD | 0.0% |
| 2008 Q2 | -842.11 Thousand USD | -88.62% |
| 2008 Q1 | -446.45 Thousand USD | 56.57% |
| 2007 Q2 | -459.68 Thousand USD | -134.25% |
| 2007 Q4 | -1.02 Million USD | -183.96% |
| 2007 Q1 | -196.23 Thousand USD | -582.18% |
| 2007 FY | -2.04 Million USD | -602.64% |
| 2007 Q3 | -362.05 Thousand USD | 21.24% |
| 2006 Q2 | -31.98 Thousand USD | -189.62% |
| 2006 FY | -291.19 Thousand USD | 39.27% |
| 2006 Q4 | -28.76 Thousand USD | 89.19% |
| 2006 Q1 | 35.69 Thousand USD | 108.58% |
| 2006 Q3 | -266.13 Thousand USD | -731.98% |
| 2005 Q1 | -3500.00 USD | 0.0% |
| 2005 Q2 | 50.33 Thousand USD | 1538.0% |
| 2005 Q3 | -75 Thousand USD | -249.03% |
| 2005 FY | -479.47 Thousand USD | -2584.64% |
| 2005 Q4 | -416.25 Thousand USD | -454.95% |
| 2004 FY | -17.86 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Medical Technologies Inc. | -926.89 Thousand USD | 100.0% |
| Ansell Limited | 76.5 Million USD | 100.0% |
| Ansell Limited | 76.5 Million USD | 100.0% |
| BG Medicine, Inc. | - USD | NaN% |
| Biotage AB (publ) | 24.28 Million USD | 100.0% |
| CB Scientific, Inc. | -1.63 Million USD | 100.0% |
| Psykey, Inc. | -1.32 Million USD | 100.0% |
| ConvaTec Group Plc | 130.3 Million USD | 100.0% |
| ConvaTec Group Plc | 130.3 Million USD | 100.0% |
| Encision Inc. | -691.78 Thousand USD | 100.0% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 100.0% |
| Hear AtLast Holdings, Inc. | -234.36 Thousand USD | 100.0% |
| Innovative MedTech Inc. | -7.93 Million USD | 100.0% |
| LifePoint, Inc. | -15.23 Million USD | 100.0% |
| Medite Cancer Diagnostics, Inc. | -6.81 Million USD | 100.0% |
| Paradigm Medical Industries, Inc. | -474 Thousand USD | 100.0% |
| QuantRx Biomedical Corporation | - USD | NaN% |
| Remedent, Inc. | -274.44 Thousand USD | 100.0% |
| Reflect Scientific, Inc. | -459.02 Thousand USD | 100.0% |
| SmileDirectClub, Inc. | -86.4 Million USD | 100.0% |
| Sector 10, Inc. | 7036.00 USD | 100.0% |
| Shandong Weigao Group Medical Polymer Company Limited | 2 Billion USD | 100.0% |
| SheerVision, Inc. | -71.37 Thousand USD | 100.0% |
| United Health Products, Inc. | -2.62 Million USD | 100.0% |
| Vasamed, Inc. | -4.88 Million USD | 100.0% |
| Wearable Health Solutions, Inc. | -2.38 Million USD | 100.0% |
| Yubo International Biotech Limited | -1.2 Million USD | 100.0% |